Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with
lomustine, etoposide, cyclophosphamide, and procarbazine in treating patients with stage IIB,
stage III, or stage IV AIDS-related Hodgkin's disease.